| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 0 | 63.534 | 92.467 | 101.063 | 115.718 |
| Total Income - EUR | - | - | - | - | - | 0 | 63.534 | 92.467 | 101.063 | 116.008 |
| Total Expenses - EUR | - | - | - | - | - | 0 | 3.872 | 14.489 | 23.104 | 38.294 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 0 | 59.662 | 77.979 | 77.958 | 77.714 |
| Net Profit/Loss - EUR | - | - | - | - | - | 0 | 57.756 | 75.777 | 76.968 | 74.304 |
| Employees | - | - | - | - | - | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Ad Natale Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 170 | 111 | 1.370 | 1.958 | 49.510 |
| Current Assets | - | - | - | - | - | 0 | 59.268 | 93.490 | 77.631 | 133.980 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 1.005 |
| Receivables | - | - | - | - | - | 0 | 18.164 | 54.179 | 546 | 2.001 |
| Cash | - | - | - | - | - | 0 | 41.105 | 39.311 | 77.085 | 130.974 |
| Shareholders Funds | - | - | - | - | - | 0 | 57.756 | 75.777 | 76.968 | 74.304 |
| Social Capital | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Debts | - | - | - | - | - | 170 | 1.623 | 19.083 | 2.622 | 109.186 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Ad Natale Med S.r.l.